China's population falls for a fourth straight year

China's population fell for a fourth consecutive year in 2025, declining by 3.39 million to 1.405 billion. Births plunged to 7.92 million (from 9.54 million in 2024) while deaths rose to 11.31 million (from 10.93 million), and marriages dropped about 20% in 2024—trends that accelerate ageing, shrink the workforce and strain pension budgets. The demographic shift undermines domestic consumption and complicates Beijing's efforts to rein in debt, though demographers expect a possible short-term uptick in births after a May 2025 marriage-registration reform.

Analysis

Market structure: A -3.39M population decline and 7.92M births in 2025 tightens long-term domestic demand—weakening consumer discretionary, autos, housing and private education while shifting pricing power toward eldercare, pharma, automation and productivity software. Lower household formation and a continued 3–5 year contraction in first-time homebuyers imply 10–20% lower incremental housing demand versus pre-2020 baselines, pressuring developers' cashflows and local-government land-sale revenues.

Risk assessment: Near-term (days–months) we expect risk-off flows into offshore US Treasuries and USD; short-term (3–12 months) credit spreads on Chinese property and LGFV debt are the highest tail risk—default cascade possible if policy remains muted. Long-term (years) structural GDP growth could undershoot consensus by 0.5–1.0ppt annually absent sustained pro-natalist or productivity offsets; an alternative tail (large fiscal stimulus + infrastructure) could rapidly reverse commodity weakness.

Trade implications: Tactical trades should short China consumer/tech cyclicals and high-yield property credit while rotating into healthcare, automation and India exposure. FX and fixed-income positioning matters: expect RMB depreciation pressure (target 3–7% over 6–12 months) and higher issuance from Beijing, so prefer selective duration and credit hedges.

Contrarian angles: Consensus underprices the speed at which automation and services for the elderly can soak up labour displacement—history (Japan) shows durable outperformance for healthcare/robotics despite decades of demographic drag. Conversely, stimulus-driven commodity rallies are an asymmetric risk to shorts; monitor M2, LGFV issuance and marriage registrations as early reversal signals.

Key Decisions for Investors

• Reduce China large-cap consumer/Internet exposure: trim KWEB and FXI weight by 2–4% of NAV over next 10 trading days and establish 3-month put spreads (buy 10% OTM puts, sell 5% OTM puts) sized to protect the trimmed amount—target cost <1.5% NAV, stop-loss if KWEB/FXI rally >8% in 30 days.
• Establish 2–3% NAV long in India equities (INDA) via spot ETF and hedge currency; supplement with 6–12 month call spread (buy 20% OTM, sell 40% OTM) to capture 12–18% upside from potential China-to-India reallocation within 12 months.
• Rotate 1.5–3% NAV into China healthcare/eldercare exposure (select large-cap lists or China healthcare ETF if available) targeting 12–36 month holding period; hedge 25–50% of China beta via short FXI to isolate sector/ageing demand.
• Hedge credit and FX tail risk: buy 6–12 month CDS protection on top-5 Chinese high-yield property issuers sized 1–2% NAV (or short CNY high-yield bonds) and enter a 6–12 month short CNH forward position sized 1–2% NAV, targeting 3–7% RMB weakness with a 1% stop against position; reassess if M2 growth >6% or PMI >50 for two consecutive months.